Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.16% Nasdaq Up0.11%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM

3.02 Down 0.02(0.66%) 12:31PM EDT - Nasdaq Real Time Price

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 12
Next Qtr.
Dec 12
Current Year
Dec 13
Next Year
Dec 13
Avg. EstimateN/AN/AN/A-0.20
No. of AnalystsN/AN/AN/A1.00
Low EstimateN/AN/AN/A-0.20
High EstimateN/AN/AN/A-0.20
Year Ago EPS-0.49-0.49N/AN/A
Revenue EstCurrent Qtr.
Sep 12
Next Qtr.
Dec 12
Current Year
Dec 13
Next Year
Dec 13
Avg. Estimate6.88B6.88B6.88B6.88B
No. of Analysts1111
Low Estimate6.88B6.88B6.88B6.88B
High Estimate6.88B6.88B6.88B6.88B
Year Ago SalesNaNNaNNaN6.88B
Sales Growth (year/est)N/AN/AN/A0.00%
Earnings HistorySep 11Dec 11Mar 12Jun 12
EPS Est-0.58-0.56-0.56-0.56
EPS Actual-0.49-0.49-0.42-0.42
Difference0.090.070.140.14
Surprise %15.50%12.50%25.00%25.00%
EPS TrendsCurrent Qtr.
Sep 12
Next Qtr.
Dec 12
Current Year
Dec 13
Next Year
Dec 13
Current EstimateN/AN/AN/A-0.20
7 Days AgoN/AN/AN/A-0.20
30 Days AgoN/AN/AN/AN/A
60 Days AgoN/AN/AN/AN/A
90 Days AgoN/AN/AN/AN/A
EPS RevisionsCurrent Qtr.
Sep 12
Next Qtr.
Dec 12
Current Year
Dec 13
Next Year
Dec 13
Up Last 7 DaysN/AN/AN/A0
Up Last 30 DaysN/AN/AN/A0
Down Last 30 DaysN/AN/AN/A0
Down Last 90 DaysN/AN/AN/AN/A
Growth EstCYCCIndustrySectorS&P 500
Current Qtr.N/AN/AN/A11.80%
Next Qtr.N/AN/AN/A16.60%
This YearN/AN/A9.70%9.10%
Next YearN/AN/A13.20%12.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A13.14%13.69%9.37%
Price/Earnings (avg. for comparison categories)N/A-0.683.2113.29
PEG Ratio (avg. for comparison categories)N/A-5.56-0.681.32
Currency in USD.